Clients and Recognition

Powerhouse attorneys for revolutionary inventions

Our clients range from large, publicly-traded companies with household names to exciting, venture-backed startups with revolutionary approaches to solving today’s problems in life sciences and biotechnology. We are thrilled to work with each of them.

  • AC Immune SA
  • Aevi Genomic Medicine, Inc. (formerly Medgenics, Inc.)
  • Cargill, Incorporated
  • Genomic Health, Inc.
  • Helsinn Healthcare SA
  • Hologic, Inc.
  • Horizon Discovery Group plc
  • Joslin Diabetes Center
  • Jounce Therapeutics, Inc.
  • Ionis Pharmaceuticals, Inc.
  • Regulus Therapeutics Inc.
  • Revitope Ltd.
  • Sanofi Pasteur SA
  • SomaLogic, Inc.
  • Thermo Fisher Scientific Inc.
  • Ultivue, Inc.

Recognition and Expertise

Even though we might be the new kid on the block, we’re getting recognition. McNeill Baur was shortlisted for Managing Intellectual Property’s “Firm to Watch” award in 2016 and 2017. The firm has been recognized as an IP Star by Managing Intellectual Property. And Rebecca M. McNeill, Amelia Feulner Baur, PhD, and Mary R. Henninger, PhD, have been recognized individually as IP Stars by Managing Intellectual Property. Amelia Feulner Baur, PhD, has also been recognized as a Super Lawyer and Rebecca M. McNeill received an AV Preeminent rating from Martindale-Hubbell.

Our attorneys and professionals have the expertise to back you in your matters. Three quarters of our attorneys and professionals have PhDs from institutions like Yale, MIT, UC Berkeley, UT Southwestern Medical Center, and Georgetown. We also have law degrees from top-ranked schools like Stanford and Georgetown. We have seen your side of the coin, having worked in both corporate legal and research departments. We have held positions at the USPTO and the NIH. And we’ve gotten our legal training from top-shelf firms widely recognized as the best in the world.